Inflammatory markers in autoimmunity induced by checkpoint inhibitors

Husain, B; Kirchberger, MC; Erdmann, M; Schupferling, S; Abolhassani, AR; Frohlich, W; Berking, C; Heinzerling, L

Heinzerling, L (corresponding author), Univ Klinikum Erlangen, Dept Dermatol, Ulmenweg 18, D-91054 Erlangen, Germany.; Heinzerling, L (corresponding author), Comprehens Canc Ctr Erlangen European Metropolita, D-91054 Erlangen, Germany.; Heinzerling, L (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Deutsch Zentrum Immuntherapie DZI, D-91054 Erlangen, Germany.; Heinzerling, L (corresponding author), Unive Klinikum Erlangen, D-91054 Erlangen, Germany.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021; 147 (6): 1623

Abstract

Purpose Immune checkpoint inhibitors (ICI) are highly effective in several cancer entities, but also invoke a variety of immune-related adverse events......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索